Lacutamab (IPH4102) is a humanized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma.
Purity:
>98.5%
CAS Number:
[2187368-16-5]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted